Sign in
Taking people in NetherlandsPhase 4

Testing one blood level check to adjust blood thinners in frail older adults

Tests one blood thinner level check and dose change in frail older adults.

Key facts

Who runs it
Academisch Ziekenhuis Maastricht
Where
Maastricht, NetherlandsSee the 2 sites
Registry title
Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients.
Status
Recruiting
Phase
Phase 4
People taking part
2,000 people, planned
Started
6 Jan 2026
Expected to end
1 Sept 2030
Type of study
Interventional
Record updated
22 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for frail older adults who take a blood thinner (a DOAC) and can give informed consent. It tests a one-time blood level check and dose adjustment.

Age
Older than 70 years
Sex
All sexes can join
Disease stage
Frail, with a Clinical Frailty Scale (CFS) score above 3
Earlier treatment
Must be using a DOAC; people who are just starting a DOAC are preferred

Main reasons for not taking part

  • Life expectancy under 3 months
  • Not able to give informed consent

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: (a) aged > 70 years; (b) using a DOAC (preferably among new users, defined as participants initiating treatment with a DOAC), (c) CFS > 3, (d) able to attend to the outpatient clinic (only applicable to community dwelling patients), and (e) able to provide informed consent

Who cannot take part

  • A potential subject who meets any of the following criteria will be excluded from participation in this study: (1) a life expectancy < 3 months, (2) not able to provide informed consent

Where in Netherlands

  • EnvidaMaastricht, NetherlandsTaking people
  • MUMC+Maastricht, NetherlandsTaking people

About the trial

What the trial wants to find out

The primary aim of this study is to evaluate the efficacy of a Single Measurement and adjustment strategy based on DOAC levels in the frail older population on the incidence of complications, in particular thromboembolic events or bleedings as composite outcome.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients: Insights from the DOAC-FRAIL RCT. A step towards safe(r) DOAC utilization in the frail older population.
Plain-language title
Testing one blood level check to adjust blood thinners in frail older adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
22 December 2025